Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
4.24
Nov 06 • 3:59 PM ET Dollar change+0.11 Percentage change(2.66%)
Aftermarket Close
4.18
Aftermarket • 7:53 PM ET Dollar change-0.06 Percentage change(-1.42%)
Category
US Equities - Factor & Thematic
Sponsor
Advisor Shares
Fund Family
Index
-
Index Weighting
Active/Passive
Expense
0.78%
Inverse/Leveraged
IPO
Sep 02, 2020
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
-
Tags
-
Tags
-
Tags
-
Sector/Theme
Region
SMA20
3.69%
SMA50
-6.96%
SMA200
-4.43%
Return% 1Y
-0.93%
Return% 3Y
-7.69%
Return% 5Y
-31.00%
Return% 10Y
Return% SI
Flows% 1M
-1.66%
Flows% 3M
-8.07%
Flows% YTD
-6.21%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
25
AUM
793.30M
NAV/sh
52W High
7.25 -41.52%
52W Low
2.96 43.24%
Volatility
7.75% 5.59%
ATR (14)
0.25
RSI (14)
49.44
Beta
1.50
Rel Volume
0.92
Avg Volume
4.99M
Volume
4,591,563
Perf Week
7.61%
Perf Month
-0.70%
Perf Quarter
-3.64%
Perf Half Y
-16.04%
Perf YTD
-10.17%
Perf Year
8.44%
Perf 3Y
-27.77%
Perf 5Y
-84.94%
Perf 10Y
-
Prev Close
4.13
Price
4.24
Change %
2.66%
AdvisorShares Pure US Cannabis ETF seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.